s6y

3 Entasis Therapeutics Holdings Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001209191-18-052232

Documents

  1. FORM 3 SUBMISSION 3
  2. POA DOCUMENT EX-24.3_810778

On sec.gov